Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Kidney Diseases
Interventions
OTHER

1 blood sample for each participant

"Blood sample for cohort n°1 and n°2 (collection during a peripheral venous blood sample, part of the standard of care for this disease) :~1 blood sample for each patient 28mL of blood (4 tubes, 7mL per tube)~Blood samples for cohort n°3 (collection during blood donation at Etablissement Français du Sang) :~1 blood sample for each healthy donor 14mL of blood (2 tubes, 7mL per tube)"

Trial Locations (1)

45067

RECRUITING

Center Hospitalier Universitaire d'Orléans, Orléans

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER